EUVIMEDEUVIMED entdecken
Crossref

Combining IMPT and spot‐scanning hadron arc to efficiently boost dose and LET in hypoxic target volumes

Guangru Li, Lennart Volz, Olga Sokol, Emanuele Scifoni, Marco Durante, Guoqing Xiao, Qiang Li, Christian Graeff

Medical Physics · 2025

DOI: 10.1002/mp.70176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Physics, 2025. Verfasst von Guangru Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Modern Physics (IMP), Chinese Academy of Sciences, Lanzhou, China. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Linear Energy Transfer, Heavy Ion Radiotherapy, Radiation Dosage. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: European Union's Horizon 2020 research and innovation program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypoxia significantly affects radiotherapy by increasing tumor radioresistance. High linear energy transfer radiation, such as carbon ion therapy, can help mitigate this issue. Carbon ion arc therapy offers the potential to increase LET in hypoxic tumor regions, offering a promising approach to improve treatment outcomes, but lacks robustness.

Purpose

We introduced and quantitatively evaluated a new heavy ion therapy treatment strategy named LE T b O ost by heavy P article A rc R a D iation (LEOPARD), which combines intensity‐modulated particle therapy (IMPT) with spot‐scanning hadron arc (SHArc) strategy. LEOPARD aims to increase dose and the dose‐averaged linear energy transfer () within the hypoxic target volume (HTV) while maintaining plan quality and robustness. IMPT and SHArcBoost are used as reference strategies for comparison.

Methods

A proof of concept for LEOPARD was realized on 15 head & neck cancer patients with an artificially contoured HTV generated from isotropic shrinking of the clinical target volume (CTV). The LEOPARD plans integrate a full arc field (0 to 358, step = 2, 180 fields) delivering a boost dose to the HTV with additional IMPT fields(10 and 170) that simultaneously provide the prescribed dose to the CTV, combining both approaches in a unified treatment plan. To evaluate the potential of LEOPARD, we compared it to intensity modulated particle therapy dose boost plans (IMPTBoost) which included 2 IMPT fields (10 and 170) for CTV, with 2 identical fields added to boost dose in HTV, and SHArc‐only boost plans (SHArcBoost) which used same arc fields as LEOPARD aimed at both CTV and HTV but without IMPT fields. Plans were evaluated for dosimetric accuracy, robustness, , and cell survival fraction considering the oxygen‐enhancement ratio. Treatment delivery times were calculated using an in‐house dynamic carbon ion arc therapy delivery simulator.

Results

LEOPARD combined treatment demonstrated a capacity to balance plan quality by mitigating the robustness issues inherent in SHArc plans while improving the LET distribution compared to IMPTBoost plans. Compared with SHArcBoost, LEOPARD showed higher mean D95 in the HTV (96.1% vs. 95.4%; ), lower mean D2 (113.2% vs. 117.0%; ) and HI (18.3% vs. 22.6%; ). Compared with IMPTBoost, mean 50 in the HTV increased by 16.9% (), and mean SF50 in the HTV reduced by 3.8% ().

Conclusion

We developed a new treatment strategy—LEOPARD, which can generate higher in the HTV than IMPTBoost, while achieving better dose distribution and plan robustness compared to SHArcBoost. This work therefore indicates promising potential of LEOPARD for the treatment of hypoxic tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiotherapy, Intensity-ModulatedLinear Energy TransferHeavy Ion RadiotherapyRadiation DosageRadiotherapy DosageHumansRadiotherapy Planning, Computer-AssistedHead and Neck Neoplasms

Stichwörter der Autor:innen

IMPTLET boosthadron archypoxia

Autor:innen und Institutionen

  • Institute of Modern Physics (IMP), Chinese Academy of Sciences, Lanzhou, China.
  • Biophysics, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany.
  • University of Chinese Academy of Sciences, Beijing, China.
  • Trento Institute for Fundamental Physics and Applications (TIFPA), National Institute for Nuclear Physics (INFN), Povo, Italy.
  • Institute of Condensed Matter Physics, Technical University of Darmstadt, Darmstadt, Germany.
  • Institute of Electrical Engineering and Information Technology, Technical University of Darmstadt, Darmstadt, Germany.

Förderung

  • European Union's Horizon 2020 research and innovation program

Zitieren

APA

Li, G., Volz, L., Sokol, O., Scifoni, E., Durante, M., Xiao, G., Li, Q., & Graeff, C. (2025). Combining IMPT and spot‐scanning hadron arc to efficiently boost dose and LET in hypoxic target volumes. Medical Physics. https://doi.org/10.1002/mp.70176

Vancouver

Li G, Volz L, Sokol O, Scifoni E, Durante M, Xiao G, et al. Combining IMPT and spot‐scanning hadron arc to efficiently boost dose and LET in hypoxic target volumes. Medical Physics. 2025. doi:10.1002/mp.70176

BibTeX
@article{Li2025,
  author = {Li, Guangru and Volz, Lennart and Sokol, Olga and Scifoni, Emanuele and Durante, Marco and Xiao, Guoqing and Li, Qiang and Graeff, Christian},
  title = {Combining IMPT and spot‐scanning hadron arc to efficiently boost dose and LET in hypoxic target volumes},
  journal = {Medical Physics},
  year = {2025},
  doi = {10.1002/mp.70176}
}
Kostenlos starten →